They are important niches to the scientists who can now solve previously unsolvable problems, but they may not constitute ...

The FDA has made some modest efforts, but it needs an internal organization that understands and would be an aggressive ...

A biotechnology company in Research Triangle Park has taken a major step to develop a new option for patients in need of a ...

Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ...

A new computational tool could help researchers identify promising drug combinations for treating cancer, according to a new ...

Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug ...

The fallout from the F.D.A.’s rejection of MDMA-assisted treatment for PTSD worries researchers and experts who fear other ...

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...

The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain medicines. View on euronews ...

GSK (GSK) announced that new drug applications have been accepted for review by the China National Medical Products Administration and submitted to the Japanese Ministry of Health, Labour and ...

has accepted for review the New Drug Application (NDA) for SL1009, Sodium Dichloroacetate Oral Solution (DCA). DCA will be used with a proprietary genetic test to treat an orphan pediatric ...